Recent Company News

• 10:57 PM ET May 13, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (225 total)

• 11:04 PM ET May 11, 2026
  

  StreetAccount Summary - Trading higher/lower: Japan mid-day

• 10:48 PM ET May 10, 2026
  

  Teijin announces 2026-2028 medium-term management plan (¥1627.0000, +60)

• 10:42 PM ET May 10, 2026
  

  Teijin reports Q4 net income attributable (¥29.0B) vs year-ago (¥22.6B) (¥1627.0000, +60)

• 10:45 PM ET Apr 21, 2026
  

  StreetAccount Sector Preview - Japan Chemicals Jan-Mar Earnings

• 11:11 PM ET Apr 09, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (73 total)

• 03:11 AM ET Mar 31, 2026
  

  Teijin guides FY net income attributable (¥95.00-85.00B) vs prior guidance (¥10.00B) and FactSet (¥8.80B) [5 est, (¥12)-(5B)] (¥1632.0000, 0)

• 08:34 AM ET Mar 17, 2026
  

  Ascendis Pharma announces positive Week 52 topline results from New InsiGHTS Phase II trial ($231.03, 0.00)

• 08:04 AM ET Mar 16, 2026
  

  New two-year data from pivotal approach trial showing durable benefits of TransCon CNP (navepegritide) in children with achondroplasia shared at ACMG 2026 ($225.98, 0.00)

• 10:21 PM ET Mar 02, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (149 total)